eMedicine Specialties > Pediatrics: General Medicine > Gastroenterology
Ulcerative Colitis: Differential Diagnoses & Workup
Updated: Sep 11, 2009
- Overview
- Differential Diagnoses & Workup
- Treatment & Medication
- Follow-up
- Multimedia
Differential Diagnoses
Amebiasis
Hemolytic-Uremic Syndrome
Henoch-Schoenlein Purpura
Irritable Bowel Syndrome
Salmonella Infection
Other Problems to Be Considered
Pseudomembranous (Clostridium difficile) colitis
Infectious colitis (due to Escherichia coli or Yersinia, Salmonella, or Shigella species)
Workup
Laboratory Studies
- CBC count commonly reveals a mild anemia, which can be due to chronic blood loss (ie, microcytic, hypochromic) or may represent chronic disease (ie, normocytic). In cases of fulminant colitis, severe anemia may be present.
- Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) level are frequently elevated during active disease.
- Result for antineutrophil cytoplasmic antibody with a perinuclear staining pattern (p-ANCA) are positive in up to 80% of patients with ulcerative colitis (UC) and in up to 20% of patients with Crohn disease (CD).
- Serum albumin levels may be low in fulminant colitis.
- Fecal calprotectin may be elevated during times of active inflammation.
- Calprotectin is a calcium-binding S-100 protein found in the neutrophil cytosol that is released with cell activation or death.
- An assay for calprotectin is now commercially available and may be useful to differentiate a disease flare from other causes of abdominal pain or diarrhea.
- Micronutrient and vitamin levels are typically low in CD but less commonly so in UC.
- Obtain stool cultures to rule out infectious colitis. Obtain an assay for E coli H7:0157 if the patient's symptoms are consistent with hemolytic uremic syndrome.
- Obtain a stool assay for C difficile toxins A and B because C difficile colitis can mimic UC or it may be responsible for a flare. Evaluation for toxin A or toxin B alone is inadequate for an accurate diagnosis of C difficile infection.
- Liver dysfunction may indicate sclerosing cholangitis or autoimmune hepatitis.
Imaging Studies
- An abdominal obstruction series (ie, supine and upright abdominal radiography) is useful to evaluate for air-fluid levels, dilated loops of bowel, evidence of obstruction, or possible toxic megacolon. No pathognomonic findings for UC on this type of study are reported.
- Barium enema study is useful to evaluate the colon for stricture and for mucosal abnormalities, especially when colonoscopy cannot be performed. Barium enema studies may also demonstrate source of bleeding other than UC, such as a polyp.
- An upper GI series with small-bowel follow-through is used to evaluate for small-bowel inflammation that would support a diagnosis of CD rather than UC.
- CT scanning of the abdomen is useful to evaluate for bowel-wall thickening and obstruction. If present, abscesses and fistulae imply a diagnosis of CD rather than UC.
- Radionuclide-tagged WBC scanning can be used to demonstrate small-bowel inflammation that differentiates CD from UC.
- MRI of the abdomen is increasingly used to evaluate the large and small bowel for inflammatory changes and to look for transmural versus mucosal inflammation.
- Wireless video capsule endoscopy, also known as the Pillcam, is an increasingly used imaging technology that may reveal small bowel involvement in inflammatory bowel disease (IBD) that differentiates CD from UC.
Procedures
- Colonoscopy with biopsy is the most valuable procedure in the evaluation of the patient with IBD.
- Typical findings in someone with UC are inflammation first evident in the rectum that proximally extends in a contiguous fashion. The mucosa typically appears erythematous, friable, and granular, and it has lost the normally visible vascular markings.
- Findings more consistent with CD than with UC are sparing of the rectal mucosa, aphthous ulceration, and noncontiguous or skip lesions.
- When possible, visualizing the entire colon and the last portion of the ileum (terminal ileum) is best because the terminal ileum is not actively involved in UC but is commonly involved in CD. However, patients with pancolitis occasionally have microscopic inflammation in the terminal ileum, which is thought to be secondary to reflux of colonic contents through an inflamed ileocecal valve (ie, backwash ileitis).
Histologic Findings
- Biopsy findings consistent with UC are polymorphonuclear leukocytes near the base of the crypts.
- Cryptitis describes aggregation of polys in the crypt epithelium, and the term crypt abscess is used when polys have accumulated in the lumen of the crypt.
- Lymphocytes, eosinophils, and mast cells may also be observed in the lamina propria in acute UC. However, no pathognomonic biopsy findings have been described for UC.
- Noncaseating granulomas are diagnostic of CD.
More on Ulcerative Colitis |
| Overview: Ulcerative Colitis |
Differential Diagnoses & Workup: Ulcerative Colitis |
| Treatment & Medication: Ulcerative Colitis |
| Follow-up: Ulcerative Colitis |
| Multimedia: Ulcerative Colitis |
| References |
| « Previous Page | Next Page » |
References
Turner D, Otley AR, Mack D, Hyams J, de Bruijne J, Uusoue K. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. Aug 2007;133(2):423-32. [Medline].
Kam L. Ulcerative colitis in young adults. Complexities of diagnosis and management. Postgrad Med. Jan 1998;103(1):45-9, 53-6, 59. [Medline].
Miele E, Pascarella F, Giannetti E, Quaglietta L, Baldassano RN, Staiano A. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol. Feb 2009;104(2):437-43. [Medline].
Ziring DA, Wu SS, Mow WS, Martín MG, Mehra M, Ament ME. Oral tacrolimus for steroid-dependent and steroid-resistant ulcerative colitis in children. J Pediatr Gastroenterol Nutr. Sep 2007;45(3):306-11. [Medline].
Mamula P, Markowitz JE, Brown KA, et al. Infliximab as a novel therapy for pediatric ulcerative colitis. J Pediatr Gastroenterol Nutr. Mar 2002;34(3):307-11. [Medline].
Eidelwein AP, Cuffari C, Abadom V, Oliva-Hemker M. Infliximab efficacy in pediatric ulcerative colitis. Inflamm Bowel Dis. Mar 2005;11(3):213-8. [Medline].
Becker JM. Surgical therapy for ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am. Jun 1999;28(2):371-90, viii-ix. [Medline].
[Guideline] Cohen JL, Strong SA, Hyman NH, et al. Practice parameters for the surgical treatment of ulcerative colitis. Dis Colon Rectum. Nov 2005;48(11):1997-2009. [Medline].
Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am. Jun 1999;28(2):255-81, vii. [Medline].
Baldassano RN, Piccoli DA. Inflammatory bowel disease in pediatric and adolescent patients. Gastroenterol Clin North Am. Jun 1999;28(2):445-58. [Medline].
Burke A, Lichtenstein GR, Rombeau JL. Nutrition and ulcerative colitis. Baillieres Clin Gastroenterol. Mar 1997;11(1):153-74. [Medline].
Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. Jul 1998;115(1):182-205. [Medline].
Hyams J, Markowitz J, Lerer T, Griffiths A, Mack D, Bousvaros A. The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol. Sep 2006;4(9):1118-23. [Medline].
Lewis JD, Deren JJ, Lichtenstein GR. Cancer risk in patients with inflammatory bowel disease. Gastroenterol Clin North Am. Jun 1999;28(2):459-77, x. [Medline].
Mack DR, Langton C, Markowitz J, LeLeiko N, Griffiths A, Bousvaros A. Laboratory values for children with newly diagnosed inflammatory bowel disease. Pediatrics. Jun 2007;119(6):1113-9. [Medline].
Michetti P, Peppercorn MA. Medical therapy of specific clinical presentations. Gastroenterol Clin North Am. Jun 1999;28(2):353-70, viii. [Medline].
Orloski LA. Pediatric ulcerative colitis: a review of the disease and current therapy. Pediatr Nurs. Mar-Apr 1998;24(2):165-7. [Medline].
Papadakis KA, Targan SR. Current theories on the causes of inflammatory bowel disease. Gastroenterol Clin North Am. Jun 1999;28(2):283-96. [Medline].
Rajwal SR, Puntis JW, McClean P, et al. Endoscopic rectal sparing in children with untreated ulcerative colitis. J Pediatr Gastroenterol Nutr. Jan 2004;38(1):66-9. [Medline].
Sanders DS. The differential diagnosis of Crohn's disease and ulcerative colitis. Baillieres Clin Gastroenterol. Mar 1998;12(1):19-33. [Medline].
Selby W. The natural history of ulcerative colitis. Baillieres Clin Gastroenterol. Mar 1997;11(1):53-64. [Medline].
Stein RB, Hanauer SB. Medical therapy for inflammatory bowel disease. Gastroenterol Clin North Am. Jun 1999;28(2):297-321. [Medline].
Weinstein TA, Levine M, Pettei MJ, et al. Age and family history at presentation of pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. Nov 2003;37(5):609-13. [Medline].
Further Reading
Keywords
ulcerative colitis, UC, fulminant colitis, ulcerative proctitis, ulcerative proctocolitis, inflammatory bowel disease, IBD, Crohn disease, Crohn's disease, CD, cryptitis, abdominal cramping, bloody stool, diarrhea, rectal bleeding, anorexia, weight loss, leukocytosis, hypoalbuminemia, severe hemorrhage, toxic megacolon, intestinal perforation, growth failure, arthropathy, tachycardia, tachypnea, anemia, hypokalemia, hypomagnesemia, hypoproteinemia, pancolitis, sclerosing cholangitis, carcinoma, pyoderma gangrenosum, uveitis, arthritis, chronic active hepatitis, granulomatous hepatitis, amyloidosis, fatty liver, pericholangitis, thromboembolic disease, factor V, factor VIII, deep venous thrombosis, pulmonary emboli, neurovascular disease
Differential Diagnoses & Workup: Ulcerative Colitis